Irvine, Calif. — November 3, 2025 — Leads & Copy — Beta Bionics, Inc. (Nasdaq: BBNX) will present at two upcoming investor conferences. The Wolfe Research 7th Annual Healthcare Conference presentation will be on Tuesday, November 18, 2025, at 2:00 p.m. ET. The Piper Sandler 37th Annual Healthcare Conference presentation will be on Tuesday, December 2, 2025, at 4:30 p.m. ET.
The presentations will be webcast live, with links available in the “Investors—Events & Presentations” section of Beta Bionics’ website. The webcasts will be archived for replay following the events.
Beta Bionics, Inc. designs, develops, and commercializes innovative solutions to improve the health and quality of life for insulin-requiring people with diabetes. The iLet Bionic Pancreas is the first FDA-cleared insulin delivery device that autonomously determines every insulin dose.
Investor Relations:Blake Beber, Head of Investor Relations, ir@betabionics.com
Media and Public Relations: Karen Hynes, Vice President of Marketing, media@betabionics.com
Source: Beta Bionics, Inc.
